QUENTIS THERAPEUTICS INC has a total of 12 patent applications. It increased the IP activity by 166.0%. Its first patent ever was published in 2017. It filed its patents most often in WIPO (World Intellectual Property Organization), United States and Canada. Its main competitors in its focus markets organic fine chemistry and pharmaceuticals are LUSOCHIMICA SPA, FORGE THERAPEUTICS INC and SILICON SWAT INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 4 | |
#2 | United States | 3 | |
#3 | Canada | 2 | |
#4 | EPO (European Patent Office) | 2 | |
#5 | China | 1 |
# | Industry | |
---|---|---|
#1 | Organic fine chemistry | |
#2 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Heterocyclic compounds | |
#2 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Vacca Joseph P | 12 |
#2 | Bettigole Sarah | 12 |
#3 | Li Dansu | 12 |
Publication | Filing date | Title |
---|---|---|
CA3064837A1 | Ire1 small molecule inhibitors | |
WO2018222917A1 | Ire1 small molecule inhibitors | |
US2018346447A1 | IRE1 small molecule inhibitors | |
EP3548476A1 | Ire1 small molecule inhibitors |